Welcome to our dedicated page for Crocs SEC filings (Ticker: CROX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Crocs, Inc. filings document the operations, governance and capital structure of a branded casual footwear company built around the Crocs and HEYDUDE brands. Form 8-K reports furnish earnings releases covering revenue, channel performance, gross margin, non-GAAP reconciliations, outlook commentary, cash flow, share repurchases and debt activity.
Proxy materials cover annual meeting matters, board and executive compensation disclosures, equity award information and pay-versus-performance data. Other material-event filings describe executive appointments and related compensatory arrangements, providing formal records of leadership and governance changes within the company.
Crocs, Inc. reported that a trust associated with Chief Executive Officer Andrew Rees sold a total of 30,000 shares of common stock on August 7 and 10, 2026 in open-market transactions. The weighted-average sale prices came from ranges between $136.78 and $140.05 per share. A separate entry shows Rees holding 570,179 shares of common stock directly as of August 7, 2026.
Crocs, Inc. (CROX) received a Form 144 notice indicating an intention to sell 19,072 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on or after August 10, 2026 on NASDAQ. The shares relate to previously granted Performance Stock Units and Restricted Stock issued as compensation. Related entities, including The Rees Family Living Trust and The Rees Family Foundation, sold additional common shares in the prior three months.
CROX has a planned sale of restricted or control securities under Rule 144. An affiliated holder intends to sell 10,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an estimated aggregate value of $1,376,400.00 on NASDAQ as of 08/07/2026.
The filing also lists prior sales within the last three months by related entities: 32,688 common shares for $3,860,282.82 by The Rees Family Living Trust on 06/05/2026, and 5,000 common shares for $538,418.00 by The Rees Family Foundation, Inc. on 05/21/2026. The 10,000 shares to be sold relate to Performance Stock Units granted on 03/17/2020 as compensation.
Crocs, Inc. insider filing indicates a planned sale of 10,928 shares of common stock through Morgan Stanley Smith Barney LLC on or about 08/07/2026 on NASDAQ, with an aggregate market value of $1,508,248.20. The filing notes 47,945,075 shares of common stock outstanding. The shares derive from Performance Stock Units granted in 2021 and 2024 as compensation. Recent sales over the past three months include 32,688 shares sold for $3,860,282.82 by The Rees Family Living Trust and 5,000 shares sold for $538,418.00 by The Rees Family Foundation, Inc.
Crocs, Inc. CEO Andrew Rees exercised 200,000 employee stock options on August 4, 2026 at an exercise price of $6.98 per share, receiving 200,000 shares of common stock. The issuer withheld 105,610 shares at $141.19 per share to cover the exercise price and tax obligations. A family trust for which Rees is trustee holds 743,293 shares of Crocs common stock with voting and investment power, and the transactions were not made under a Rule 10b5-1 trading plan.
FMR LLC and Abigail P. Johnson report beneficial ownership of common stock of Crocs, Inc. on an amended Schedule 13G. They report beneficial ownership of 3,507,502 shares of Crocs common stock, representing 7.1% of the class as of June 30, 2026.
FMR LLC has sole voting power over 3,362,891.33 shares and sole dispositive power over 3,507,502 shares, with no shared voting or dispositive power. Abigail P. Johnson reports sole dispositive power over the same 3,507,502 shares and no voting or shared dispositive power.
One or more other persons have the right to receive dividends or sale proceeds from these shares, but no such person has an interest equal to or exceeding five percent of Crocs’ outstanding common stock. Subsidiaries involved in holding the securities are identified in an attached Exhibit 99.
Crocs, Inc. reported record second quarter 2026 results, with consolidated revenue of $1,179 million, up 2.6% year over year. Direct-to-consumer revenue grew 12.0% while wholesale declined 7.2%. The Crocs Brand generated $1.0 billion in quarterly revenue for the first time, rising 4.3%, while HEYDUDE revenue fell 5.7% to $179 million.
Gross margin was 59.4% (60.0% on a non-GAAP basis) versus 61.7% a year ago. Income from operations was $286 million, compared to a prior-year loss driven by HEYDUDE impairment charges. GAAP diluted EPS reached $4.13 and non-GAAP diluted EPS $4.55, an increase of 7.6%.
Supported by strong cash flow generation, the company repaid $31 million of debt and repurchased approximately 2.3 million shares for $251 million in the quarter. On July 27, the board increased the share repurchase authorization by $1.5 billion, leaving approximately $2.0 billion available. Based on first-half performance, Crocs raised full-year 2026 guidance, now expecting revenue growth of 1–2% and non-GAAP diluted EPS of $13.70–$14.00, with third-quarter revenue roughly flat year over year and adjusted EPS of $3.20–$3.30.
FRASCH RONALD reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. director Ronald Frasch received an equity grant of common stock as part of his board compensation. He was awarded 1,252 shares of common stock on June 9, 2026 at a stated price of $0.00 per share, reflecting a non-cash compensation award.
According to the filing, this represents the annual common stock grant to non-employee directors under the company’s Board of Directors Compensation Plan. Following this grant, Frasch directly holds a total of 76,180 shares of Crocs common stock.
Bickley Ian reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. disclosed that director Ian Bickley received an equity award of common stock. On June 9, 2026, he was granted 1,252 shares of Common Stock at a price of $0.00 per share as an annual grant for non-employee directors.
Following this award, Bickley directly holds 31,609 shares of Crocs common stock. The footnote explains that this represents the annual common stock grant made under the company’s Board of Directors Compensation Plan, reflecting routine, compensation-related equity rather than an open-market purchase.